Suppr超能文献

催乳素与其二聚化受体复合物的晶体结构揭示了激素结合位点 2 的拓扑结构。

Crystal structure of an affinity-matured prolactin complexed to its dimerized receptor reveals the topology of hormone binding site 2.

机构信息

Laboratoire de Cristallographie et RMN Biologiques, CNRS, UMR 8015, Université Paris Descartes, 75006 Paris, France.

出版信息

J Biol Chem. 2010 Mar 12;285(11):8422-33. doi: 10.1074/jbc.M109.089128. Epub 2010 Jan 6.

Abstract

We report the first crystal structure of a 1:2 hormone.receptor complex that involves prolactin (PRL) as the ligand, at 3.8-A resolution. Stable ternary complexes were obtained by generating affinity-matured PRL variants harboring an N-terminal tail from ovine placental lactogen, a closely related PRL receptor (PRLR) ligand. This structure allows one to draw up an exhaustive inventory of the residues involved at the PRL.PRLR site 2 interface, consistent with all previously reported site-directed mutagenesis data. We propose, with this description, an interaction model involving three structural components of PRL site 2 ("three-pin plug"): the conserved glycine 129 of helix alpha3, the hydrogen bond network involving surrounding residues (glycine cavity), and the N terminus. The model provides a molecular basis for the properties of the different PRL analogs designed to date, including PRLR antagonists. Finally, comparison of our 1:2 PRL.PRLR(2) structure with those of free PRL and its 1:1 complex indicates that the structure of PRL undergoes significant changes when binding the first, but not the second receptor. This suggests that the second PRLR moiety adapts to the 1:1 complex rather than the opposite. In conclusion, this structure will be a useful guiding tool for further investigations of the molecular mechanisms involved in PRLR dimerization and activation, as well as for the optimization of PRLR antagonists, an emerging class of compounds with high therapeutic potential against breast and prostate cancer.

摘要

我们报告了第一个涉及催乳素(PRL)作为配体的 1:2 激素-受体复合物的晶体结构,分辨率为 3.8-A。通过生成具有来自绵羊胎盘催乳素(与 PRL 受体(PRLR)配体密切相关)N 端尾巴的亲和力成熟的 PRL 变体,获得了稳定的三元复合物。该结构允许人们详细列出涉及 PRL.PRLR 位点 2 界面的残基,与所有先前报道的定点突变数据一致。我们提出了一个涉及 PRL 位点 2 的三个结构成分的相互作用模型(“三销塞”):α3 螺旋的保守甘氨酸 129、涉及周围残基的氢键网络(甘氨酸腔)和 N 端。该模型为迄今为止设计的不同 PRL 类似物的特性提供了分子基础,包括 PRLR 拮抗剂。最后,将我们的 1:2 PRL.PRLR(2)结构与游离 PRL 及其 1:1 复合物的结构进行比较表明,当结合第一个而不是第二个受体时,PRL 的结构会发生显着变化。这表明第二个 PRLR 部分适应 1:1 复合物而不是相反。总之,该结构将成为进一步研究 PRLR 二聚化和激活涉及的分子机制以及优化 PRLR 拮抗剂的有用指导工具,PRLR 拮抗剂是一类具有治疗乳腺癌和前列腺癌高潜力的新兴化合物。

相似文献

6
Solution structure of human prolactin.人催乳素的溶液结构
J Mol Biol. 2005 Aug 26;351(4):810-23. doi: 10.1016/j.jmb.2005.06.042.

引用本文的文献

4
Leveraging a natural murine meiotic drive to suppress invasive populations.利用自然的小鼠减数分裂驱动来抑制入侵种群。
Proc Natl Acad Sci U S A. 2022 Nov 15;119(46):e2213308119. doi: 10.1073/pnas.2213308119. Epub 2022 Nov 8.

本文引用的文献

1
Phaser crystallographic software.相位结晶学软件。
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674. doi: 10.1107/S0021889807021206. Epub 2007 Jul 13.
2
Structure and function of a new class of human prolactin antagonists.一类新型人催乳素拮抗剂的结构与功能
Protein Expr Purif. 2009 Aug;66(2):121-30. doi: 10.1016/j.pep.2009.02.012. Epub 2009 Feb 21.
3
Case-controlled structure validation.病例对照结构验证。
Acta Crystallogr D Biol Crystallogr. 2009 Feb;65(Pt 2):140-7. doi: 10.1107/S0907444908041085. Epub 2009 Jan 20.
7
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids.MolProbity:蛋白质和核酸的全原子接触与结构验证
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83. doi: 10.1093/nar/gkm216. Epub 2007 Apr 22.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验